Your browser doesn't support javascript.
loading
Repeat stereotactic radiosurgery for progressive vestibular schwannomas after primary gamma knife radiosurgery.
Taori, Suchet; Bin-Alamer, Othman; Tang, Anthony; Niranjan, Ajay; Flickinger, John C; Hadjipanayis, Constantinos G; Lunsford, L Dade.
Affiliation
  • Taori S; School of Medicine, University of Pittsburgh Medical Center, Pennsylvania, PA, USA.
  • Bin-Alamer O; Department of Neurological Surgery, University of Pittsburgh Medical Center, 200 Lothrop Street, Pennsylvania, PA, 15213, USA. oabinalamer@gmail.com.
  • Tang A; School of Medicine, University of Pittsburgh Medical Center, Pennsylvania, PA, USA.
  • Niranjan A; School of Medicine, University of Pittsburgh Medical Center, Pennsylvania, PA, USA.
  • Flickinger JC; Department of Neurological Surgery, University of Pittsburgh Medical Center, 200 Lothrop Street, Pennsylvania, PA, 15213, USA.
  • Hadjipanayis CG; Department of Radiation Oncology, University of Pittsburgh Medical Center, Pennsylvania, PA, USA.
  • Lunsford LD; School of Medicine, University of Pittsburgh Medical Center, Pennsylvania, PA, USA.
J Neurooncol ; 169(3): 591-599, 2024 Sep.
Article de En | MEDLINE | ID: mdl-39073686
ABSTRACT

PURPOSE:

Limited data provides guidance on the management of vestibular schwannomas (VSs) that have progressed despite primary Gamma Knife radiosurgery (GKRS). The present article reports our long-term experience after repeat GKRS for VS with sustained progression after solely primary GKRS management.

METHODS:

A retrospective review of 1997 patients managed between 1987 and 2023 was conducted. Eighteen patients had sustained tumor progression after primary GKRS and underwent repeat GKRS. The median repeat GKRS margin dose was 11 Gy (IQR 11-12), the median tumor volume was 2.0 cc (IQR 1.3-6.3), and the median cochlear dose in patients with preserved hearing was 3.9 Gy (IQR 3-4.1). The median time between initial and repeat GKRS was 65 months (IQR 38-118).

RESULTS:

The median follow-up was 70 months (IQR 23-101). After repeat GKRS, two patients had further tumor progression at 4 and 21 months and required partial resection of their tumors. The 10-year actuarial tumor control rate after repeat GKRS was 88%. Facial nerve function was preserved in 13 patients who had House-Brackmann grade 1 or 2 function at the time of repeat GKRS. Two patients with serviceable hearing preservation (Gardner-Robertson grade 1 or 2) at repeat GKRS retained that function afterwards. In patients with tinnitus, vestibular dysfunction, and trigeminal neuropathy, symptoms remained stable or improved for 16/16 patients, 12/15 patients, and 10/12 patients, respectively. One patient developed facial twitching in the absence of tumor growth 21 months after repeat GKRS.

CONCLUSIONS:

Repeat GKRS effectively controlled tumor growth and preserved cranial nerve outcomes in most patients whose VS had sustained progression after initial primary radiosurgery.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Neurinome de l'acoustique / Radiochirurgie / Évolution de la maladie Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: J Neurooncol Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Neurinome de l'acoustique / Radiochirurgie / Évolution de la maladie Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: J Neurooncol Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique